Raws li nws cov neeg siv, LGD 3303 yog ib qho ntawm SARMS zoo tshaj plaws rau tag nrho lub zog thiab kev loj hlob. Qhov no xaiv androgen receptor modulator los nrog flawless qhov ncauj bioavailability. Thaum noj, SARM no khi rau androgen receptor nrog siab affinity thiab selectivity. Yog li ntawd, nws ua rau muaj kev nce ntxiv hauv cov leeg nqaij thiab qhov loj me.
Yeej, nws tso cai rau cov neeg siv los siv qhov SARM qhov siab tshaj plaws nrog kev siv qhov ncauj yooj yim. Yog, kuv nyiam qhov ntawd thiab - qhov tseeb, nws txhais tau tias koj yuav tsis tas yuav muaj dab tsi ua nrog koob.
LGD 3303 yog officially categorized raws li ib tug xaiv agonist rau lub androgen receptor. Hais txog yuav ua li cas androgenic nws yog, nws yog tag nrho agonist ntawm cov leeg thiab ib feem agonist ntawm prostate. Nws muab ob qho tib si androgenic thiab anabolic teebmeem thiab tam sim no yog ib feem ntawm kev tshawb fawb txog kev kho pob txha.
